PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1127438
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1127438
Zygomatic and Pterygoid implant Market size was valued at USD 306.8 Million in 2021, growing at a CAGR of 5.1% from 2022 to 2028.
Long implants, such as zygomatic and pterygoid implants, are used when the patient's number or quality of bones is insufficient to support the anchoring of conventional-sized implants. In these circumstances, tougher bones (such as those near the cheekbone area) are used to attach the implants because they consistently maintain their density and rigidity.
The main primary reason for the growth of Zygomatic and Pterygoid implants are the rising older population and the occurrence of dental disorders and traumas. Resorption and pneumatization of the maxillary sinus bone, a prevalent illness in the elderly population, cause severe maxillary bone atrophy. Without requiring complicated bone augmentation surgery, zygomatic implant surgery has a high success rate in treating atrophic jaws. Furthermore, the rapid acceptance of new technology and the favourable reimbursement for dental implants have significantly aided the expansion of the overall regional industry. The market for zygomatic and pterygoid implants is expected to benefit from improvements in zygomatic implant placement brought about by advances in 3D reconstruction. The expansion opportunities have been boosted by advancements in surgical implant guiding. The chances are being boosted by favourable reimbursement policies and technology advancements.
Market growth is also felicitated by the ageing population's increased prevalence of dental diseases and injuries as well as established implant-based techniques' advantages over conventional alternatives. For instance, according to a World Health Organization (WHO) statement from October 2020, by 2030, 1 in 6 individuals worldwide will be 60 years of age or older. With an increase in the number of elderly people, the need for zygomatic and pterygoid implants is anticipated to rise. This is because the ageing population is more likely to experience dental conditions such as maxillary resorption and increasing bone loss. Additionally, the use of these implants in operations that have been shown to be beneficial is a significant element in demand for zygomatic and pterygoid implants.
The Global Zygomatic and Pterygoid implant Market is segmented on the basis of Type, Application and Region.
The market is divided into the following categories based on type: Up to 30 mm, 31 to 40 mm, 41 to 50 mm, and Others. The 31 to 40 mm segment dominates the global Zygomatic and Pterygoid implant market with more than 41.3% of the market share. This is the most used length of zygomatic & pterygoid implants.
The market is divided into three categories based on application: Severe Atrophy of Maxillary Bone, Maxillary Sinuses, and Other Applications. Severe atrophy of the maxillary bone segment dominates the global zygotic and pterygoid market with 71.2% in 2021. Zygomatic & pterygoid implants key industry participants are primarily focusing on R&D for the following applications.
The global market for Zygomatic and Pterygoid is made of a number of both international and local producers, making it a fairly competitive sector in the world. Important initiatives adopted by key participants to expand their presence include strategic agreements, expanding their distribution networks, investment in R&D, and mergers and acquisitions. In December 2020, a premium dental clinic in Singapore, Nuffield Dental Group, announced the launch of its 10th dental technology clinic in Singapore. At Nuffield, zygomatic implants are an alternate treatment for issues with low bone density in the patient's upper jaw.
The scope of this report covers the market by its major segments, which include as follows: